Detail akcie BNB Plus Corp online

Business Summary: BNB Plus Corp., formerly Applied DNA Sciences, Inc., is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The Company is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, BNB Plus Corp revenues increased 1% to $2.1M. Net loss applicable to common stockholders excluding extraordinary items increased from $6.9M to $69.1M. Revenues reflect Therapeutic DNA production segment increase of 10% to $988K, Asia and other segment increase of 3% to $1M. Higher net loss reflects Therapeutic DNA production segment loss increase of 94% to $9.3M.